GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newland Pharmaceutical Co Ltd (SZSE:301277) » Definitions » Gross Profit

Newland Pharmaceutical Co (SZSE:301277) Gross Profit : ¥273.7 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Newland Pharmaceutical Co Gross Profit?

Newland Pharmaceutical Co's gross profit for the three months ended in Mar. 2024 was ¥80.4 Mil. Newland Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ¥273.7 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Newland Pharmaceutical Co's gross profit for the three months ended in Mar. 2024 was ¥80.4 Mil. Newland Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥184.6 Mil. Therefore, Newland Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2024 was 43.56%.

Newland Pharmaceutical Co had a gross margin of 43.56% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of Newland Pharmaceutical Co was 45.44%. The lowest was 23.52%. And the median was 39.97%.


Newland Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Newland Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newland Pharmaceutical Co Gross Profit Chart

Newland Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 164.97 196.81 206.02 223.36 259.51

Newland Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.19 69.30 64.14 59.89 80.41

Competitive Comparison of Newland Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Newland Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newland Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newland Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Newland Pharmaceutical Co's Gross Profit falls into.



Newland Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Newland Pharmaceutical Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=651.437 - 391.923
=259.5

Newland Pharmaceutical Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=184.583 - 104.174
=80.4

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥273.7 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Newland Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=80.4 / 184.583
=43.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Newland Pharmaceutical Co  (SZSE:301277) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Newland Pharmaceutical Co had a gross margin of 43.56% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Newland Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Newland Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Newland Pharmaceutical Co (SZSE:301277) Business Description

Traded in Other Exchanges
N/A
Address
East side of the south section of Weiwu Road, Henan Province, Changge, CHN, 461500
Newland Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chiral pharmaceutical intermediates.

Newland Pharmaceutical Co (SZSE:301277) Headlines

No Headlines